Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 26, 2018 - Issue 6
Submit an article Journal homepage
328
Views
13
CrossRef citations to date
0
Altmetric
Original Articles

Pediatric Uveitis in a Well-Defined Population: Improved Outcomes with Immunosuppressive Therapy

David S. CurraghDepartment of Ophthalmology, Royal Victoria Hospital, Belfast, UKCorrespondence[email protected]
, MB BCh BaO, FRCOphth,
Marie O’NeillDepartment of Ophthalmology, Royal Victoria Hospital, Belfast, UK
, MRCOphth,
Clara E. McAvoyDepartment of Ophthalmology, Royal Victoria Hospital, Belfast, UK
, MB BCh, BaO, MRCOphth,
Madeleine RooneyCentre for Experimental Medicine, Queens University of Belfast, Belfast, UK
, MB BCh, BAO, MRCO DCH MD &
Eibhlin McLooneDepartment of Ophthalmology, Royal Victoria Hospital, Belfast, UK
, MB BCh, BAO, FRCOphth
Pages 978-985 | Received 30 Oct 2016, Accepted 08 Mar 2017, Published online: 27 Apr 2017

REFERENCES

  • BenEzra D, Cohen E, Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol. 2005;89:444–448.
  • Azar D, Martin F. Paediatric uveitis: a Sydney clinic experience. Clin Experiment Ophthalmol. 2004;32:468–471.
  • Edelsten C, Reddy MA, Stanford MR, Graham EM. Visual loss associated with pediatric uveitis in English primary and referral centers. Am J Ophthalmol. 2003;135:676–680.
  • Kadayifcilar S, Eldem B, Tumer B. Uveitis in childhood. J Pediatr Ophthalmol Strabismus. 2003;40:335–340.
  • Cunningham ET Jr. Uveitis in children. Ocul Immunol Inflamm. 2000;8:251–261.
  • Jabs DA, Nussenblatt RB, Rosenbaum JT, et al. For The Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
  • Petty RE, Southwood TR, Manners P, et al. International League of Associations for rheumatology classification of juvenile idiopathic arthritis: second revision. Edmonton, 2001. J Rheumatol. 2004;31:390–392.
  • Northern Ireland Statistics and Research Agency. Available at: http://www.nisra.gov.uk/demography/default.asp42.htm. Accessed May 13, 2016.
  • Ganesh SK, Aparna B, Biswas L, et al. Pattern of paediatric uveitis seen at tertiary referral centre from India. Ocular Immunol Inflamm. 2016;24(4):402–409.
  • Clarke LAL, Guex-Crosier Y, Hofer M. Epidemiology of uveitis in children over a 10-year period. Clin Exp Rheumatol. 2013;31:633–637.
  • Smith JA, Mackensen F, Sen HN et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009; 116(8): 1544–1551.
  • Gregory AC, Kempen JH, Daniel E, et al. Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: the systemic immunosuppressive therapy for eye diseases study. Ophthalmology. 2013;120:186–192.
  • Levy-Clarke G, Jabs DA, Read RW, et al. Expert panel recommendations for the use of anti-tumour necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology. 2014;121:785–796.
  • Couto C, Frick MM, LaMattina K, et al. Chronic anterior uveitis in children. Ocul Immunol Inflamm. 2016;24:392–396.
  • Ramanan AV, Dick AD, Benton D, et al. SYCAMORE Trial Management Group. A randomised controlled trial of the cost-effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis (SYCAMORE Trial). Trials. 2014;15:14.
  • Ramanan AV, Dick AD, Benton D, et al. SYCAMORE Trial Management Group. Adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis: the SYCAMORE trial. Ann Rheum Dis. 2016;75:264.
  • Cunningham ET Jr, Smith JR, Tugal-Tutkun I, et al. Uveitis in children and adolescents. Ocul Immunol Inflamm. 2016;24(4):365–371.
  • Paroli MP, Spinucci G, Liverani M, et al. Uveitis in childhood: an Italian clinical and epidemiological study. Ocular Immunol Inflamm. 2009;17:238–242.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.